With the Port of Baltimore all but closed, how will the supply chain be impacted?

Mar 27, 2024

2 min

Richard Franza, PhD

Following the incident of the container ship crashing into the Francis Scott Key Bridge at the Port of Baltimore and the bridge collapsing, there are now some supply chain concerns. While they may not be felt right away by consumers, there are a number of businesses that will be affected by it.



Rick Franza, PhD, professor in Augusta University's James M. Hull College of Business and an expert on operations and supply chain management, said one immediate impact is where container ships will be diverted to for offloading.


The Port of Baltimore is a major shipping hub and ranks first among U.S. ports for autos and light trucks. Now those ships will have to find other ports to unload their goods, which becomes a logistical problem as much as anything.


“Most ports on the East Coast are at 70% to 80% capacity, which is where you want to be. You don’t want to have much more than that, but they’re going to have to,” said Franza. “It could affect a good bit of the eastern half of the United States.”


Ports in Savannah, Charleston and New York, among others, will have to become the destination for those currently sitting outside Baltimore and those en route from around the world.


The good news, Franza said, is that most foreign car manufacturers have plants in the United States so it will likely only affect those consumers looking for a certain brand or even a specific model.



Baltimore is also one of the furthest inland ports and has the best rail service coming from it. The outbound goods coming off the ships will now face more of a transportation hurdle when they are diverted to another port.


“It’s not just the capacity of the port, that’s one thing, but it’s also their capacity of the outbound items,” he said. “It may be more trucks are needed, and new routes are needed to move inventory. It now becomes a whole different set of providers for the trucks because it’s no longer the people in Baltimore.”


Franza added companies will also have to decide which distribution centers they may want to use, whether it’s closer to the area they serve or closer to the port. All those factors affect where the items from overseas end up.


While it’s not a good scenario, at the end of the day, he feels the consumer likely won’t see much of an impact.


 “First of all it’s going to take a while before we see any effect on certain things,” Franza said. “The bad news for inflation is that it’s going to raise the cost of transportation for the goods coming off the ships. Will businesses absorb the cost or pass them along to consumers?”


Looking to know more? Then let us help.


Richard Franza, PhD, is available to speak with media about trending issues like inflation, small business and the economy – simply click on his icon now to arrange an interview today.

Connect with:
Richard Franza, PhD

Richard Franza, PhD

Faculty, James M. Hull College of Business

Dr. Richard M. Franza is a professor and former dean of the James M. Hull College of Business.

ManagementOperations ResearchEntreprenuershipIntentional LeadershipHigher Education Leadership
Powered by

You might also like...

Check out some other posts from Augusta University

Can a Mother's ZIP Code Shape a Baby's Future? featured image

2 min

Can a Mother's ZIP Code Shape a Baby's Future?

Where an expectant mother lives might reveal important clues about her baby's health before birth. According to a recent Augusta University Jagwire article, researchers at the Medical College of Georgia have found that mapping birth outcomes by ZIP code can help identify communities where mothers and newborns face greater health risks, providing valuable information for healthcare providers and public health officials. The two-part study out of the Department of Anesthesiology and Perioperative Medicine at the Medical College of Georgia at Augusta University, led by Mary Arthur, MD, explored the relationship between neighborhood characteristics and neonatal outcomes. By combining geographic mapping with maternal and infant health data, the researchers identified areas with higher rates of adverse birth outcomes and examined how factors such as access to prenatal care and other social determinants of health might contribute to those disparities. The findings suggest that geographic data can become a valuable tool for improving maternal and infant health. By identifying communities at greater risk, healthcare systems and policymakers can better target prenatal education, outreach programs and healthcare resources to support expectant mothers before complications arise. For journalists covering maternal health, healthcare disparities and public policy, Arthur offers valuable insight into how community-level data can help guide interventions that improve pregnancy outcomes and give more babies a healthier start in life. "The maps make it very easy to visualize those ZIP codes that link to poor neonatal outcomes. They're also helpful for planning strategic interventions to help the people who live in those particular areas in terms of making sure there are outreach programs for mothers in those areas to have access to prenatal care." Mary Arthur, MD To learn more about this important research and connect with Mary Arthur, contact AU's External Communications Team mediarelations@augusta.edu to arrange an interview today.

Can One Gene Change the Future of Heart Disease? featured image

2 min

Can One Gene Change the Future of Heart Disease?

Heart disease remains the world's leading cause of death, but researchers are continuing to uncover the genetic mechanisms that drive it. According to a recent Augusta University Jagwire article highlighting new research, scientists are investigating how a little-studied gene might influence the development of cardiovascular disease and whether it could become a future target for treatment. At the center of the research is Kunzhe Dong, PhD, an investigator at Augusta University's Immunology Center of Georgia, who is examining the role of the SH3BGRL2 gene in cardiovascular cells. While the gene has previously been associated with cancer biology, early findings suggest it might also play an important role in regulating how blood vessels respond to stress and injury. Understanding that relationship could reveal new biological pathways involved in heart disease and identify novel opportunities for precision medicine. The research aims to determine how changes in gene expression affect the function of cardiovascular cells and contribute to disease progression. By better understanding these molecular mechanisms, scientists hope to identify new therapeutic targets and improve the ability to prevent or treat cardiovascular disease before irreversible damage occurs. The work also reflects a broader shift toward precision medicine, where treatments are tailored to the underlying biology of each patient rather than relying solely on traditional risk factors. "This gene is well known in one field, but now we're seeing it's also important in cardiovascular cells." Kunzhe Dong, PhD To learn more about this research and connect with Kunzhe Dong, contact AU's External Communications Team mediarelations@augusta.edu to arrange an interview today.

Heart Disease's Hidden Immune Players Come Into Focus featured image

2 min

Heart Disease's Hidden Immune Players Come Into Focus

Heart disease has long been linked to familiar risk factors such as high cholesterol, high blood pressure and lifestyle choices. But according to a recent Augusta University Jagwire article highlighting research published in Nature Reviews Cardiology, the immune system might also play a critical role in determining how cardiovascular disease develops and progresses. The review, led by Ishita Tandon, PhD, Hossam Abdelsamed, PhD, and Alaa M. Khalifa, PhD, examines the emerging role of CD8+ T cells, specialized immune cells best known for fighting infections, in atherosclerosis, the chronic inflammatory disease responsible for most heart attacks and strokes. By synthesizing the latest evidence, the researchers show how different populations of these immune cells can either fuel inflammation or help regulate it, revealing new opportunities to better understand, diagnose and eventually treat cardiovascular disease. The review also identifies important gaps in current knowledge and outlines promising directions for future research. As scientists continue to better understand how these immune cells behave within arterial plaques, their discoveries could lead to more precise diagnostic tools and a new generation of immune-targeted therapies for cardiovascular disease. Together, the researchers' work offers journalists valuable insight into one of the fastest-evolving areas of cardiovascular research, where immunology and heart health are converging to reshape how cardiovascular disease is understood and treated. "This study highlights the major role of CD8+ T cells in atherosclerosis and their potential impact on cardiovascular diseases."  Hossam Abdelsamed, PhD To learn more about this amazing research and connect with Ishita Tandon, Hossam Abdelsamed or Alaa M. Khalifa, contact AU's External Communications Team mediarelations@augusta.edu to arrange an interview today.

View all posts